167 related articles for article (PubMed ID: 34459063)
21. Downregulation of nitrogen permease regulator like-2 activates PDK1-AKT1 and contributes to the malignant growth of glioma cells.
Huang N; Cheng S; Mi X; Tian Q; Huang Q; Wang F; Xu Z; Xie Z; Chen J; Cheng Y
Mol Carcinog; 2016 Nov; 55(11):1613-1626. PubMed ID: 26455908
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of Nitrogen Permease Regulator Like-2 (NPRL2) Enhances Sensitivity to Irinotecan (CPT-11) in Colon Cancer Cells by Activating the DNA Damage Checkpoint Pathway.
Liu S; Liu B
Med Sci Monit; 2018 Mar; 24():1424-1433. PubMed ID: 29519997
[TBL] [Abstract][Full Text] [Related]
23. Targeting CPT1B as a potential therapeutic strategy in castration-resistant and enzalutamide-resistant prostate cancer.
Abudurexiti M; Zhu W; Wang Y; Wang J; Xu W; Huang Y; Zhu Y; Shi G; Zhang H; Zhu Y; Shen Y; Dai B; Wan F; Lin G; Ye D
Prostate; 2020 Sep; 80(12):950-961. PubMed ID: 32648618
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of PDZ-binding kinase confers malignant phenotype in prostate cancer via the regulation of E2F1.
Chen JH; Liang YX; He HC; Chen JY; Lu JM; Chen G; Lin ZY; Fu X; Ling XH; Han ZD; Jiang FN; Zhong WD
Int J Biol Macromol; 2015 Nov; 81():615-23. PubMed ID: 26314905
[TBL] [Abstract][Full Text] [Related]
25. NUSAP1 expression is upregulated by loss of RB1 in prostate cancer cells.
Gordon CA; Gulzar ZG; Brooks JD
Prostate; 2015 Apr; 75(5):517-26. PubMed ID: 25585568
[TBL] [Abstract][Full Text] [Related]
26. E2F1 renders prostate cancer cell resistant to ICAM-1 mediated antitumor immunity by NF-κB modulation.
Ren Z; Kang W; Wang L; Sun B; Ma J; Zheng C; Sun J; Tian Z; Yang X; Xiao W
Mol Cancer; 2014 Apr; 13():84. PubMed ID: 24742333
[TBL] [Abstract][Full Text] [Related]
27. Upregulation of MircoRNA-370 induces proliferation in human prostate cancer cells by downregulating the transcription factor FOXO1.
Wu Z; Sun H; Zeng W; He J; Mao X
PLoS One; 2012; 7(9):e45825. PubMed ID: 23029264
[TBL] [Abstract][Full Text] [Related]
28. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
29. Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer.
Wu Z; He B; He J; Mao X
Prostate; 2013 May; 73(6):596-604. PubMed ID: 23060044
[TBL] [Abstract][Full Text] [Related]
30. miR-96 promotes cell proliferation and clonogenicity by down-regulating of FOXO1 in prostate cancer cells.
Yu JJ; Wu YX; Zhao FJ; Xia SJ
Med Oncol; 2014 Apr; 31(4):910. PubMed ID: 24633705
[TBL] [Abstract][Full Text] [Related]
31. Differential regulation of MMPs by E2F1, Sp1 and NF-kappa B controls the small cell lung cancer invasive phenotype.
Li Z; Guo Y; Jiang H; Zhang T; Jin C; Young CY; Yuan H
BMC Cancer; 2014 Apr; 14():276. PubMed ID: 24755270
[TBL] [Abstract][Full Text] [Related]
32. E2F1 enhances glycolysis through suppressing Sirt6 transcription in cancer cells.
Wu M; Seto E; Zhang J
Oncotarget; 2015 May; 6(13):11252-63. PubMed ID: 25816777
[TBL] [Abstract][Full Text] [Related]
33. Integrative Analysis Reveals the Transcriptional Collaboration between EZH2 and E2F1 in the Regulation of Cancer-Related Gene Expression.
Xu H; Xu K; He HH; Zang C; Chen CH; Chen Y; Qin Q; Wang S; Wang C; Hu S; Li F; Long H; Brown M; Liu XS
Mol Cancer Res; 2016 Feb; 14(2):163-172. PubMed ID: 26659825
[TBL] [Abstract][Full Text] [Related]
34. Increased expression of NuSAP in recurrent prostate cancer is mediated by E2F1.
Gulzar ZG; McKenney JK; Brooks JD
Oncogene; 2013 Jan; 32(1):70-7. PubMed ID: 22349817
[TBL] [Abstract][Full Text] [Related]
35. MiR-1/GOLPH3/Foxo1 Signaling Pathway Regulates Proliferation of Bladder Cancer.
Liu MK; Ma T; Yu Y; Suo Y; Li K; Song SC; Zhang W
Technol Cancer Res Treat; 2019; 18():1533033819886897. PubMed ID: 31714185
[TBL] [Abstract][Full Text] [Related]
36. Elevated E2F1 inhibits transcription of the androgen receptor in metastatic hormone-resistant prostate cancer.
Davis JN; Wojno KJ; Daignault S; Hofer MD; Kuefer R; Rubin MA; Day ML
Cancer Res; 2006 Dec; 66(24):11897-906. PubMed ID: 17178887
[TBL] [Abstract][Full Text] [Related]
37. Competitive Binding Between Id1 and E2F1 to Cdc20 Regulates E2F1 Degradation and Thymidylate Synthase Expression to Promote Esophageal Cancer Chemoresistance.
Li B; Xu WW; Guan XY; Qin YR; Law S; Lee NP; Chan KT; Tam PY; Li YY; Chan KW; Yuen HF; Tsao SW; He QY; Cheung AL
Clin Cancer Res; 2016 Mar; 22(5):1243-55. PubMed ID: 26475334
[TBL] [Abstract][Full Text] [Related]
38. Reactivation of the tumour suppressor RASSF1A in breast cancer by simultaneous targeting of DNA and E2F1 methylation.
Montenegro MF; Sáez-Ayala M; Piñero-Madrona A; Cabezas-Herrera J; Rodríguez-López JN
PLoS One; 2012; 7(12):e52231. PubMed ID: 23251702
[TBL] [Abstract][Full Text] [Related]
39. E2F transcription factor 1/small nucleolar RNA host gene 18/microRNA-338-5p/forkhead box D1: an important regulatory axis in glioma progression.
Ma Q; Yang T
Bioengineered; 2022 Jan; 13(1):418-430. PubMed ID: 34937497
[TBL] [Abstract][Full Text] [Related]
40. Adenovirus E2F1 overexpression sensitizes LNCaP and PC3 prostate tumor cells to radiation in vivo.
Udayakumar TS; Stoyanova R; Hachem P; Ahmed MM; Pollack A
Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):549-58. PubMed ID: 21195876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
